Unixell’s off-the-shelf stem cell therapy cleared for US clinical trials
Clinical trials of UX-DA003, an experimental stem cell therapy for Parkinson’s disease developed by Unixell Biotechnology, can now begin in the U.S. following clearance from the Food and Drug…